Inhibition of atherogenesis in LDLR knockout mice by systemic delivery of adeno-associated virus type 2-hIL-10
- 30 September 2006
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 188 (1), 19-27
- https://doi.org/10.1016/j.atherosclerosis.2005.10.029
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The distribution of cardiac macrophages in myocardial ischaemia and cardiomyopathyHistopathology, 2005
- Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cellsCancer Gene Therapy, 2004
- Generation of Recombinant Skinin Vitroby Adeno-Associated Virus Type 2 Vector TransductionTissue Engineering, 2004
- A new HMG-CoA reductase inhibitor, pitavastatin remarkably retards the progression of high cholesterol induced atherosclerosis in rabbitsAtherosclerosis, 2004
- Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient miceGene Therapy, 2004
- IL-10 inhibits vascular smooth muscle cell activation in vitro and in vivoAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Adeno‐associated virus seropositivity and HPV‐induced cervical cancer in Spain and ColombiaInternational Journal of Cancer, 2001
- Reduced prevalence of serum antibodies against adeno‐associated virus type 2 in patients with adult T‐cell leukaemia lymphomaJournal of Medical Virology, 2001
- Transduction and Utility of the Granulocyte-Macrophage Colony-Stimulating Factor Gene into Monocytes and Dendritic Cells by Adeno-Associated VirusJournal of Interferon & Cytokine Research, 2000
- Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit.Hypertension, 1989